Extreme heat has caused more than 24,000 deaths since 1992 and has...
Category:
Health
Latest
Principal Secretary to PM chairs high-level meeting amid COVID-19 rise, stresses on 5-fold strategy
India recorded 12,591 new Covid cases in a day, the highest in...
India overtakes China to become most populous country: UN report
The latest UNFPA report stated that in India 25 per cent of the...
Home health care improves COVID-19 outcomes: Study
“Our findings suggest that acute care providers might carefully consider which COVID-19 survivors would benefit from home health care after hospitalization,” writes Kathryn H. Bowles, Ph.D., RN, FAAN, FACMI, Professor of Nursing and van Ameringen Chair in Nursing Excellence at Penn Nursing
“
SII to seek emergency-use authorisation of COVID-19 vaccine in 2-weeks:Poonawalla
“The vaccine will be distributed initially in India, and then we will look at the COVAX countries, mainly in Africa. The UK and European markets are being taken care of by AstraZeneca and Oxford. Our priority is India and COVAX countries,” he said, adding they can do under-18 trails after a few months.
h
UK regulator set to approve COVID-19 vaccine next week – FT
The government asked the regulator on Friday to assess AstraZeneca Plc’s COVID-19 vaccine for a possible rollout. It has secured 100 million doses of the vaccine developed by AstraZeneca and Oxford University and has targeted a rollout to begin before Christmas.
New Delhi ambulance group grapples with surging COVID-19 quarantine deaths
Currently more than 23,000 people are recovering at home in Delhi, which has been recording a total of around 100 deaths a day this month and more than 5,000 infections.
“Corona has gone out of control in Delhi,” said Shunty, who founded the non-governmental organisation more than 25 years ago. It runs 16 ambulances, almost all of them working overtime these days.
“Too many deaths are happening, especially among the old and people with other complications.”
Pharma firm in India to make Russia’s Sputnik V COVID-19 vaccine
Kirill Dmitriev, RDIF head, said earlier this week that Moscow and its foreign partners had the capacity to make more than a billion doses of Sputnik V starting from next year — enough to vaccinate over 500 million people — and that it would cost under $20 per person on international markets.
UK asks regulator to assess AZ-Oxford vaccine amid questions
The step comes amid questions about preliminary results from trials of the jab, after the company and the university acknowledged that the most encouraging part of their findings stemmed from a dosing error.
UK Health Secretary Matt Hancock said he had asked the Medicines and Healthcare Products Regulatory Agency (MHRA) to determine whether the vaccine “meets rigorous safety standards.”
Suspected North Korean hackers targeted COVID vaccine maker AstraZeneca –
Cyberattacks against health bodies, vaccine scientists and drugmakers have soared during the COVID-19 pandemic as state-backed and criminal hacking groups scramble to obtain the latest research and information about the outbreak.
Western officials say any stolen information could be sold for profit, used to extort the victims, or give foreign governments a valuable strategic advantage as they fight to contain a disease that has killed 1.4 million people worldwide.
No need for vaccines, Covid effectively over: Ex-Pfizer VP
“You do not vaccinate people who aren’t at risk from the disease. You also don’t set about planning to vaccinate millions of fit and healthy people with a vaccine that hasn’t been extensively tested on human subjects,” Dr Michael Yeadon, its former Vice President and Chief Scientist said.
Covid-19 virus may hijack our cells’ cholesterol system to spread through body:says study
They say this hints at new targets for treatment, although this is very early-stage research.
The study suggests that SARS-CoV-2 may use the cell’s internal cholesterol mechanisms to enhance infection.
Indian economy contracts 7.5 pc in Q2, recovery seen next year
Economists have marginally raised growth forecasts this month after a pick-up in consumer demand for autos, non-durables and rail freight during the festival season.
“The possibility of a release of several highly effective vaccines soon gives us hope that there is an end date to the pandemic Rumki Majumdar, economist at Deloitte India, while expressing confidence in a quick economic rebound.